These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 2825038

  • 1. Opposing actions of D-1 and D-2 dopamine receptor-mediated alterations of adenosine-3',5'-cyclic monophosphate (cyclic AMP) formation during the amphetamine-induced release of endogenous dopamine in vitro.
    Azzaro AJ, Liccione J, Lucci J.
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Aug; 336(2):133-8. PubMed ID: 2825038
    [Abstract] [Full Text] [Related]

  • 2. Different roles for type A and type B monoamine oxidase in regulating synaptic dopamine at D-1 and D-2 receptors associated with adenosine-3',5'-cyclic monophosphate (cyclic AMP) formation.
    Liccione J, Azzaro AJ.
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Feb; 337(2):151-8. PubMed ID: 2835690
    [Abstract] [Full Text] [Related]

  • 3. Endogenous dopamine functionally activates D-1 and D-2 receptors in striatum.
    Kelly E, Nahorski SR.
    J Neurochem; 1987 Jul; 49(1):115-20. PubMed ID: 3035091
    [Abstract] [Full Text] [Related]

  • 4. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
    Thomas KL, Rose S, Jenner P, Marsden CD.
    Biochem Pharmacol; 1992 Jul 07; 44(1):83-91. PubMed ID: 1321631
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Release of endogenous dopamine and cholecystokinin from rat striatal slices: effects of amphetamine and dopamine antagonists.
    Hutchison JB, Strupish J, Nahorski SR.
    Brain Res; 1986 Apr 09; 370(2):310-4. PubMed ID: 3708329
    [Abstract] [Full Text] [Related]

  • 8. Stimulation of D2-receptors in rat nucleus accumbens slices inhibits dopamine and acetylcholine release but not cyclic AMP formation.
    Stoof JC, Verheijden PF, Leysen JE.
    Brain Res; 1987 Oct 13; 423(1-2):364-8. PubMed ID: 2823991
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Amphetamine induced release of endogenous dopamine in vitro is not reduced following pretreatment with reserpine.
    Niddam R, Arbilla S, Scatton B, Dennis T, Langer SZ.
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Apr 13; 329(2):123-7. PubMed ID: 4010791
    [Abstract] [Full Text] [Related]

  • 11. D2-dopamine receptor-mediated inhibition of cyclic AMP formation in striatal neurons in primary culture.
    Weiss S, Sebben M, Garcia-Sainz JA, Bockaert J.
    Mol Pharmacol; 1985 Jun 13; 27(6):595-9. PubMed ID: 2987658
    [Abstract] [Full Text] [Related]

  • 12. Dissociation of the striatal D-2 dopamine receptor from adenylyl cyclase following 6-hydroxydopamine-induced denervation.
    Thomas KL, Rose S, Jenner P, Marsden CD.
    Biochem Pharmacol; 1992 Jul 07; 44(1):73-82. PubMed ID: 1321630
    [Abstract] [Full Text] [Related]

  • 13. Muscarinic receptor activation attenuates D2 dopamine receptor mediated inhibition of acetylcholine release in rat striatum: indications for a common signal transduction pathway.
    Drukarch B, Schepens E, Stoof JC.
    Neuroscience; 1990 Jul 07; 37(1):1-9. PubMed ID: 1978737
    [Abstract] [Full Text] [Related]

  • 14. Effect of sulpiride on amphetamine-induced behaviour in relation to changes in striatal dopamine release in vivo.
    Sharp T, Zetterström T, Ljungberg T, Ungerstedt U.
    Eur J Pharmacol; 1986 Oct 07; 129(3):411-5. PubMed ID: 3780853
    [Abstract] [Full Text] [Related]

  • 15. Differential effects of selective and non-selective neuroleptics on intracellular and extracellular cyclic AMP accumulation in rat striatal slices.
    Lazareno S, Marriott DB, Nahorski SR.
    Brain Res; 1985 Dec 30; 361(1-2):91-8. PubMed ID: 2867811
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. M-1 and M-2 muscarinic receptor-mediated inhibition of dopamine-sensitive adenylate cyclase in rat neostriatum: a permissive role for D-2 dopamine receptors.
    Schoffelmeer AN, Hogenboom F, Mulder AH.
    J Pharmacol Exp Ther; 1988 May 30; 245(2):658-63. PubMed ID: 2452877
    [Abstract] [Full Text] [Related]

  • 18. Effect of dopamine D-1 and D-2 receptor selective drugs on dopamine release and metabolism in rat striatum in vivo.
    Zetterström T, Sharp T, Ungerstedt U.
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct 30; 334(2):117-24. PubMed ID: 2946964
    [Abstract] [Full Text] [Related]

  • 19. Acetylcholine release in rat nucleus accumbens is regulated through dopamine D2-receptors.
    Wedzony K, Limberger N, Späth L, Wichmann T, Starke K.
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Sep 30; 338(3):250-5. PubMed ID: 3264055
    [Abstract] [Full Text] [Related]

  • 20. The role of D1 and D2 dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum.
    Delfs JM, Kelley AE.
    Neuroscience; 1990 Sep 30; 39(1):59-67. PubMed ID: 1982467
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.